Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 5-HT1B receptor: behavioral implications.

M S Clark1, J F Neumaier

  • 1Department of Psychiatry and Behavioral Sciences, Harborview Medical Center, University of Washington, Seattle, USA.

Psychopharmacology Bulletin
|October 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics for studying and understanding polar life.

Nature communications·2023
Same author

Metabarcoding the Antarctic Peninsula biodiversity using a multi-gene approach.

ISME communications·2023
Same author

Antimicrobial resistance in Antarctica: is it still a pristine environment?

Microbiome·2022
Same author

Renal Contrast on CT Myelography: Diagnostic Value in Patients with Spontaneous Intracranial Hypotension.

AJNR. American journal of neuroradiology·2019
Same author

RAD sequencing resolves fine-scale population structure in a benthic invertebrate: implications for understanding phenotypic plasticity.

Royal Society open science·2017
Same author

The transcriptome of metamorphosing flatfish.

BMC genomics·2016
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

5-HT1B receptors in the brain influence mood and behavior. Research suggests their activity is linked to antidepressant effects and impulse control, making them potential drug targets.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • 5-HT1B receptors are widely distributed in the mammalian central nervous system.
  • They function as inhibitory autoreceptors and heteroreceptors on neuronal axon terminals.
  • These receptors modulate the release of key neurotransmitters like serotonin, GABA, acetylcholine, and glutamate.

Purpose of the Study:

  • To review evidence on the role of 5-HT1B receptors in modulating behavior.
  • To explore the potential of 5-HT1B receptors as therapeutic targets for neurological and psychiatric disorders.

Main Methods:

  • Review of existing animal studies investigating 5-HT1B receptor function.
  • Analysis of human genetic studies linking 5-HT1B receptor variations to behavioral phenotypes.
  • Synthesis of evidence regarding the impact of receptor activity on neurotransmitter release and behavior.

Related Experiment Videos

Main Results:

  • Reduced 5-HT1B heteroreceptor activity is associated with increased impulsive behaviors.
  • Reduced 5-HT1B autoreceptor activity may contribute to antidepressant-like effects.
  • Evidence suggests 5-HT1B receptors play a role in drug reinforcement, stress, mood, anxiety, and aggression.

Conclusions:

  • 5-HT1B receptors are implicated in the mechanisms of action of antidepressants.
  • Targeting 5-HT1B receptors presents a promising future therapeutic strategy for various psychiatric conditions.
  • Further research is warranted to fully elucidate the therapeutic potential of modulating 5-HT1B receptor activity.